Health & Biotech
Vital Signs Podcast
Trending on Stockhead
-
Gold Digger: Gold bulls hit snooze, but there's more than rates at play
-
Criterion: Listed pet minder gives investors paws for thought
-
Scott Power: Which stock fell off its perch on poor trial results this week?
-
Monsters of Rock: Canberra forecasters see iron ore price decline ... again
-
Closing Bell: ASX drops to three-month low, while CHESS system outage halts settlements
-
Barry FitzGerald: Wildcat Resources has a target on its back after bottom of the market lithium takeovers
-
Pivotal moment? How to position as Fed turns hawkish amid stubborn inflation
-
High Voltage: Novonix accuses China's cheap graphite of blocking US domestic producers
-
ASX Lunch Wrap: ASX takes another big hit as Bitcoin trades below US$97k
-
Resources Top 5: Leeuwin pivots to gold in Ramelius deal